Pharmacyclics' IPO

Pharmacyclics raised a round of funding on October 24, 1995. Investors include Public.

Pharmacyclics aims to build a viable biopharmaceutical company that develops and commercializes novel therapies intended to improve quality of life, increase duration of life, and resolve serious medi…

Articles about Pharmacyclics' IPO: